Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Alicia Bailén Garcia"'
Autor:
Eduardo Ríos Herranz, Antonio Alcalá Muñoz, Gemma Ramirez, Antonio Fernández Jurado, José Joaquín Ruíz Arredondo, Francisco Javier Capote Huelva, José Luís Guzmán Zamudio, Miguel Ángel Álvarez Rivas, Alicia Bailén Garcia
Publikováno v:
Hematology and Leukemia. 6:4
Background: The most common therapy in young multiple myeloma patients include induction, mobilization, collection and graft of peripheral blood stem cells. The present phase 2, multi-center, randomized study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58451ce45a4221216ddc8689b023116b
https://doi.org/10.7243/2052-434x-6-4
https://doi.org/10.7243/2052-434x-6-4
Autor:
Alicia Bailén Garcia, Ma Dolores López García-Carreño, Jose Baquero, Alfons Soler, Paz Ribas, Silvia López, Raúl Pérez, Jose Ramón Mayans, Manuel Jurado, A Gutiérrez, Ma Carmen Menchaca Echevarría, Gemma Ramirez, Inmaculada Castillo, Ma Sol Durán, Miguel T. Hernandez
Publikováno v:
European journal of haematology. 96(4)
Therapeutic approaches against multiple myeloma (MM) have largely changed during the past decade. Hematopoietic stem cell transplantation (HSCT) and licensing of immunomodulators and proteasome inhibitors have resulted in better response and increase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f81c171bfe6f1b3dbdd92e0f35010a28
https://pubmed.ncbi.nlm.nih.gov/26190662
https://pubmed.ncbi.nlm.nih.gov/26190662
Autor:
Kati Hurst, Alicia Bailén Garcia, Concepción Bethencourt Mateos, Eva Mingot Castellano, Patricia Ainhoa Fuentes Galvez, Ana Isabel Heiniger Mazo
Publikováno v:
Blood. 120:4407-4407
Abstract 4407 Introduction: The treatment of acquired aplastic anemia (AA) is based on allogeneic hematopoietic cell transplantation (HCT) and immunosuppressive therapy (IST). The choice between immunosuppression or HCT is based on the availability o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9aa9ef7ea18851753ff5f1c2991a0a95
https://doi.org/10.1182/blood.v120.21.4407.4407
https://doi.org/10.1182/blood.v120.21.4407.4407
Publikováno v:
Blood. 118:5040-5040
Abstract 5040 Clinical Experience with Azacitidine In Chronic myelomonocytic leukemia (CMML) in Spain Pablo González Navarro 1*, Regina García Delgado 2*, Alicia Bailén Garcia 3*, Juan Antonio Muñoz Muñoz 4* 1MD, PhD. Hospital San Cecilio,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f207395fab7ec9b0cfb0a86478c0b6a
https://doi.org/10.1182/blood.v118.21.5040.5040
https://doi.org/10.1182/blood.v118.21.5040.5040
Autor:
Silvia López, Ma Sol Durán, Alicia Bailén Garcia, Consuelo Garcia, Ma Dolores López García-Carreño, Paz Ribas, Jose Baquero, Alfons Soler, Javier de la Rubia, A Gutiérrez, Gemma Ramirez, Inmaculada Castillo, Ma Carmen Menchaca Echevarría, Miguel T. Hernandez, Manuel Jurado
Publikováno v:
Blood. 118:4166-4166
Abstract 4166 INTRODUCTION: The purpose of this epidemiological retrospective study was to describe the natural history, clinical features, treatment and outcome of a wide population of multiple myeloma (MM) patients during a 2-year period. MATERIALS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::885eb10062e8a27d80ea6040e2bc8180
https://doi.org/10.1182/blood.v118.21.4166.4166
https://doi.org/10.1182/blood.v118.21.4166.4166